Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | NQO2 | P16083 | 2/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10504488 | 1.00 | ALDH1A1 (0.52) | ALDH1A1KDM4EMAPTHPGDCYP3A4 | |
| SCHEMBL13344132 | 0.84 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTHPGDCYP3A4 | |
| SCHEMBL1758410 | 0.79 | CYP2A6 (0.38) | KDM4EMAPTNPSR1CYP2A6LMNA | |
| SCHEMBL11908074 | 0.79 | CYP2A6 (0.38) | KDM4EMAPTNPSR1CYP2A6LMNA | |
| SCHEMBL4630831 | 0.77 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTHPGDCYP3A4 | |
| SCHEMBL1758893 | 0.77 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTHPGDCYP3A4 | |
| SCHEMBL11830929 | 0.77 | TRPA1 (0.43) | MAPTCYP1A2PTGS1PTGS2TRPA1 | |
| SCHEMBL11830924 | 0.77 | TRPA1 (0.43) | MAPTCYP1A2PTGS1PTGS2TRPA1 | |
| SCHEMBL28472907 | 0.76 | TRPA1 (0.52) | ALDH1A1CYP3A4TSHRNR1I2LMNA | |
| SCHEMBL4630810 | 0.76 | ALDH1A1 (0.53) | ALDH1A1KDM4EMAPTHPGDCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2496674-B1 | ODORANTS WITH ANISIC NOTES | FIRMENICH & CIE (CH) | 2013-06-26 | — | — | EP | disclosed |
| US-8410042-B2 | Odorants with anisic notes | FIRMENICH SA (CH) | 2013-04-02 | — | — | US | disclosed |
| EP-2496674-A1 | ODORANTS WITH ANISIC NOTES | Firmenich S.A. (CH) | 2012-09-12 | — | — | EP | disclosed |
| US-20120208741-A1 | ODORANTS WITH ANISIC NOTES | FIRMENICH SA (CH) | 2012-08-16 | — | — | US | disclosed |
| WO-2011051834-A1 | ODORANTS WITH ANISIC NOTES | FIRMENICH SA (CH) | 2011-05-05 | — | — | WO | disclosed |
| US-4863926-A | ANTICOAGULANTS, HYPOTENSIVE AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-05 | — | — | US | disclosed |
| US-4782088-A | HYPOTENSIVE, ANTITHROMBOTIC | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| US-4778804-A | ANTICOAGULANTS, HYPOTENSIVE AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-10-18 | — | — | US | disclosed |
| US-4767768-A | ANTITHROMBIC, HYPOTENSIVE; OXIME-SUBSTITUTED | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-08-30 | — | — | US | disclosed |
| EP-0113106-B1 | NEW NITRO ALIPHATIC COMPOUNDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0113106-A1 | New nitro aliphatic compounds, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208741-A1 | ODORANTS WITH ANISIC NOTES | C1S, ACMSD, CRAT | ALDH1A1 87/4885KDM4E 1421/4885MAPT 4086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.